Compounds with super-aspirin effects

A compound having the structural formula (I) and pharmaceutically acceptable salt and/or hydrates thereof, (I) wherein Y is an arylester or an C1-C8 alkylaryl ester, selected from the group consisting of: benzene, toluene, xylene, benzoic acid, benzoate, nicotinate, isonicotinate and halobenzene, which can be unsubstituted or substituted with at least one nitric oxide releasing group; and/or at least one of hydroxide, -Cl, -Br, a C1-C8 alkyl, benzyl, a C1-C8 alkoxy, benzyloxy, -NHC(O)R, -NH2, -NO2, -ONO2, -(CH2)nONO2, -OC(O)[(CH2)m], cyclic ONO2, -OCOArONO2, -OCOAr(CH2)nONO2 or a C1-C5 haloalkyl ester, wherein R is a C1-C8 alkyl or a C1-C8 alkoxy group, n=1-8 and m=3-10, to produce a super-aspirin effect.